This video demonstrates a case of catamenial pneumothorax treated with a unique robotic surgical technique involving rotation of the robot to allow for optimal visualization during separate portions of the procedure.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
June 11, 2025
This video demonstrates a robotic-assisted multiportal intrathoracic resection of a complex goiter using the da Vinci Xi system, following a previous transcervical approach.
June 11, 2025
This video demonstrates the repair of a traumatic diaphragm hernia with partial gastrectomy.
June 10, 2025
This video demonstrates a robotic anterior basilar segmentectomy, which is a safe and effective approach for early-stage non-small cell lung cancer with 3D CT reconstruction aiding preoperative planning and intraoperative visualization of complex bronchovascular anatomy.
June 5, 2025
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning recaps the 33rd European Society of Thoracic Surgeons (ESTS) annual meeting in Budapest.
June 5, 2025
This video demonstrates the case of a 67-year-old male who was found to have a right lower lobe carcinoid tumor invading bronchus intermedius; thus, a robotic-assisted right middle and lower lobe bilobectomy was performed.
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer
June 5, 2025
This study evaluated the SHURUI single-port (SP) robotic system for uniportal robotic-assisted thoracic surgery (RATS) in lung cancer patients.
June 5, 2025
This article discusses a promising diagnostic approach aimed at improving patient selection for immune checkpoint inhibitor (ICI) therapies, particularly in non-small cell lung cancer (NSCLC). The current reliance on PD-L1 immunohistochemistry (IHC) as a biomarker has limited sensitivity and specificity.
June 5, 2025
This study investigated the long-term outcomes of hardware removal (HR) in patients who had previously undergone surgical fixation for blunt chest trauma, with a median of 11.5 rib fractures stabilized per patient. A retrospective review spanning 2017 to 2023 was performed, with follow-up assessments conducted approximately 28 months after HR.
June 5, 2025
This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung cancer (NSCLC).